Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?
GR Connors, L Christopher-Stine, CV Oddis, SK Danoff - Chest, 2010 - journal.chestnet.org
The idiopathic inflammatory myopathies (IIMs) affect more than 60,000 individuals in the
United States and an estimated 770,000 worldwide. 1 Although widely considered a disease …
United States and an estimated 770,000 worldwide. 1 Although widely considered a disease …
Idiopathic inflammatory myopathies and the lung
JC Lega, Q Reynaud, A Belot, N Fabien… - European …, 2015 - Eur Respiratory Soc
Idiopathic inflammatory myositis (IIM) is a group of rare connective tissue diseases (CTDs)
characterised by muscular and extramuscular signs, in which lung involvement is a …
characterised by muscular and extramuscular signs, in which lung involvement is a …
[HTML][HTML] Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy …
Objectives To determine prevalence and co-existence of myositis specific autoantibodies
(MSAs) and myositis associated autoantibodies (MAAs) and associated clinical …
(MSAs) and myositis associated autoantibodies (MAAs) and associated clinical …
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
K Kurasawa, S Arai, Y Namiki, A Tanaka… - …, 2018 - academic.oup.com
Objective We aimed to determine the outcome of combination therapy with tofacitinib (TOF)
in a case series of refractory rapidly progressive interstitial lung disease (ILD) associated …
in a case series of refractory rapidly progressive interstitial lung disease (ILD) associated …
Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
R Aggarwal, E Cassidy, N Fertig, DC Koontz… - Annals of the …, 2014 - ard.bmj.com
Objective To compare the cumulative survival and event free survival in patients with Jo-1
versus non-Jo-1 anti-tRNA synthetase autoantibodies (anti-synAb). Methods Anti-synAb …
versus non-Jo-1 anti-tRNA synthetase autoantibodies (anti-synAb). Methods Anti-synAb …
Short‐term and long‐term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients
I Marie, PY Hatron, S Dominique, P Cherin… - Arthritis & …, 2011 - Wiley Online Library
Objective This study was undertaken to assess the characteristics and outcome of interstitial
lung disease (ILD) in polymyositis/dermatomyositis (PM/DM) and to determine variables …
lung disease (ILD) in polymyositis/dermatomyositis (PM/DM) and to determine variables …
The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody
R Nakashima, Y Imura, S Kobayashi, N Yukawa… - …, 2010 - academic.oup.com
Objectives. Various autoantibodies are detected in the sera of PM/DM patients. Some of
them are specific to PM/DM patients and closely associated with clinical manifestations of …
them are specific to PM/DM patients and closely associated with clinical manifestations of …
[HTML][HTML] Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease
H Hozumi, T Fujisawa, R Nakashima, T Johkoh… - Respiratory …, 2016 - Elsevier
Abstract Objectives Myositis-specific autoantibodies (MSAs) are associated with clinical
phenotypes in polymyositis/dermatomyositis (PM/DM). No study has investigated the clinical …
phenotypes in polymyositis/dermatomyositis (PM/DM). No study has investigated the clinical …
Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression
H Gunawardena, ZE Betteridge, NJ McHugh - Rheumatology, 2009 - academic.oup.com
The idiopathic inflammatory myopathies (IIMs)—DM and PM—have been historically defined
by broad clinical and pathological criteria. These conditions affect both adults and children …
by broad clinical and pathological criteria. These conditions affect both adults and children …
Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive …
S Sato, M Kuwana, T Fujita, Y Suzuki - Modern rheumatology, 2013 - Taylor & Francis
Objectives: We examined the relationship between disease activity and anti-CADM-
140/MDA5 titer measured by enzyme-linked immunosorbent assay (ELISA). Methods: Sera …
140/MDA5 titer measured by enzyme-linked immunosorbent assay (ELISA). Methods: Sera …